Published in Lab Business Week, March 23rd, 2008
Cellvizio Inc. is the U.S. subsidiary of Paris-based Mauna Kea Technologies and develops and markets Cellvizio, a fundamentally new endoscopic imaging approach which could improve patient care by eliminating the need for unnecessary biopsies and could enhance the diagnosis of a broad range of diseases via in vivo cellular imaging.
The Cellvizio GI procedure...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.